Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Giulia, Spada"'
Autor:
Giada Crescioli, Alessandra Bettiol, Roberto Bonaiuti, Marco Tuccori, Marco Rossi, Annalisa Capuano, Silvia Pagani, Giulia Spada, Mauro Venegoni, Giuseppe Danilo Vighi, Guido Mannaioni, Alfredo Vannacci, Niccolò Lombardi, MEREAFaPS Study group
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: There is a significant gap in knowledge addressing cardiovascular (CV) medications safety in elderly. In this context, our purposes were to define clinical and pharmacological characteristics of outpatients’ adverse drug events (ADEs) r
Externí odkaz:
https://doaj.org/article/626697ecfa0a4a7b8aa3ad5bb6dae11a
Autor:
Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Daria Bettoni, Corrado Blandizzi, Valentina Borsi, Errica Cecchi, Irma Convertino, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Giuditta Violetta Vighi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundAdverse drug event (ADEs) are a significant cause of emergency department (ED) visits and consequent hospitalization. Preventing ADEs and their related ED visits in outpatients remains a public health safety challenge. In this context, the
Externí odkaz:
https://doaj.org/article/9018384e433b4a9bad78df6444709026
Autor:
Giada Crescioli, Ennio Boscia, Alessandra Bettiol, Silvia Pagani, Giulia Spada, Giuditta Violetta Vighi, Roberto Bonaiuti, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Niccolò Lombardi, on behalf of the MEREAFaPS Study Group
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 678 (2021)
This post hoc analysis of an Italian active pharmacovigilance study describes pharmacological differences of ADEs leading to emergency department (ED) visits and hospitalization in women and men. During the study period (January 2007–December 2018)
Externí odkaz:
https://doaj.org/article/1cc4b65143aa453fa946a238995f6fd2
Autor:
Silvia Molteni, Eleonora Filosi, Maria Martina Mensi, Giulia Spada, Chiara Zandrini, Federica Ferro, Matteo Paoletti, Anna Pichiecchio, Ilaria Bonoldi, Umberto Balottin
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
In children and adolescents, schizophrenia is one of the ten main causes of disability-adjusted life years. The identification of people at Clinical High Risk of developing Psychosis (CHR-P) is one of the most promising strategies to improve outcomes
Externí odkaz:
https://doaj.org/article/5604a91309db460fac08e41944ccdb33
Autor:
Paolo Fusar-Poli, Dominic Oliver, Giulia Spada, Rashmi Patel, Robert Stewart, Richard Dobson, Philip McGuire
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
Background: Primary indicated prevention in individuals at-risk for psychosis has the potential to improve the outcomes of this disorder. The ability to detect the majority of at-risk individuals is the main barrier toward extending benefits for the
Externí odkaz:
https://doaj.org/article/14d790eea0a340b18def63a9905c908f
Autor:
Dominic Oliver, Maite Arribas, Joaquim Radua, Gonzalo Salazar de Pablo, Andrea De Micheli, Giulia Spada, Martina Maria Mensi, Magdalena Kotlicka-Antczak, Renato Borgatti, Marco Solmi, Jae Il Shin, Scott W. Woods, Jean Addington, Philip McGuire, Paolo Fusar-Poli
Publikováno v:
Molecular Psychiatry. 27:3670-3678
Accurate prognostication of individuals at clinical high-risk for psychosis (CHR-P) is an essential initial step for effective primary indicated prevention. We aimed to summarise the prognostic accuracy and clinical utility of CHR-P assessments for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03e5416f3fb26785955043db3f109ce2
https://doi.org/10.1038/s41380-022-01611-w
https://doi.org/10.1038/s41380-022-01611-w
Publikováno v:
Schizophrenia Research. 228:547-554
Improving outcomes of a First Episode of Psychosis (FEP) relies on the ability to detect most individuals with emerging psychosis and treat them in specialised Early Intervention (EI) services. Efficacy of current detection strategies is undetermined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fae6e3a3e6c04f12a737fbd936d267
https://doi.org/10.1016/j.schres.2020.11.031
https://doi.org/10.1016/j.schres.2020.11.031
Autor:
Dominic Oliver, Daniel Stahl, Craig Colling, Richard Dobson, Matthew Broadbent, Helen Baldwin, Robert Stewart, Giulia Spada, Philip McGuire, Rashmi Patel, Paolo Fusar-Poli
Publikováno v:
Schizophrenia Research
Background Risk estimation models integrated into Electronic Health Records (EHRs) can deliver innovative approaches in psychiatry, but clinicians' endorsement and their real-world usability are unknown. This study aimed to investigate the real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c96699d2e26e1595cfb0ddd5a6dd659
https://doi.org/10.1016/j.schres.2020.05.007
https://doi.org/10.1016/j.schres.2020.05.007
Autor:
Paolo Fusar-Poli, Amir Englund, Dominic Oliver, Philip McGuire, Edward Chesney, Rudolf Uher, Abraham Reichenberg, Joaquim Radua, Giulia Spada
Publikováno v:
Schizophrenia Research
Background The Psychosis Polyrisk Score (PPS) is a potential biomarker integrating non-purely genetic risk/protective factors for psychosis that may improve identification of individuals at risk and prediction of their outcomes at the individual subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb96f5486a36d10b62207ee3dbb4d289
https://doi.org/10.1016/j.schres.2020.04.015
https://doi.org/10.1016/j.schres.2020.04.015
Autor:
Silvia, Pagani, Niccolò, Lombardi, Giada, Crescioli, Violetta Giuditta, Vighi, Giulia, Spada, Paola, Andreetta, Annalisa, Capuano, Alfredo, Vannacci, Mauro, Venegoni, Giuseppe Danilo, Vighi, On Behalf Of The MEREAFaPS Study Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 10; Pages: 2811
The aim of the present study is to describe pharmacological characteristics of drug-related allergies and anaphylaxis leading to the emergency department (ED). An 8-year post hoc analysis on the MEREAFaPS Study database was performed (2012–2019). S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1bd13d1610633a02f8198fb43fef141
https://pubmed.ncbi.nlm.nih.gov/35628936
https://pubmed.ncbi.nlm.nih.gov/35628936